![](/img/cover-not-exists.png)
A phase II study of high-dose celecoxib and metronomic 'low-dose' cyclophosphamide and methotrexate in patients with relapsed and refractory lymphoma
El Bary, Naser Abd, Hashem, Tarek, Metwally, Hasan, Ghany, Ashraf Abd, El Mageed, Hager AbdVolume:
3
Language:
english
Journal:
Hematology/Oncology and Stem Cell Therapy
DOI:
10.1016/s1658-3876(10)50051-7
Date:
January, 2010
File:
PDF, 226 KB
english, 2010